Funding round
Alto Pharmacy Series D
Alto Pharmacy, which works in prescription medication fulfillment services in San Francisco, raised $250M in a Series D round announced on 30 Jan 2020, led by SoftBank Vision Fund, at a $700M post-money valuation. 5 firms took part. It is Alto Pharmacy's second venture round on record; the one before was a Series C in Dec 2018.
$250M
Amount raised
$700M
Post-money valuation
$450M pre-money
5
Investors
1 lead
36%
Stake sold
new money over the post-money
Valuation
What this round says about the price
This round priced Alto Pharmacy at $700M after the new money. The $250M bought investors about 36% of the company. It came 13 months after Alto Pharmacy's Series C. It is 50% of the $500M Alto Pharmacy has raised in the venture rounds on record. Alto Pharmacy raised again 24 months later: a Series E round of $200M in Jan 2022, at $1.70B post-money.
Alto Pharmacy's funding rounds
Alto Pharmacy has 4 venture rounds on record and 1 other deal. This one is highlighted.
Investors
Who put money in
SoftBank Vision Fund led the round with 4 other firms.
Lead investor
- SoftBank Vision Fund backs 234 venture-backed companies new investor
Also in the round
- Greenoaks backs 77 venture-backed companies new investor
- backs 29 venture-backed companies new investor
- backs 35 venture-backed companies new investor
- Zola Global new investor
Use of proceeds
What the money is for
According to the announcement, the money goes to geographic expansion, sales and marketing, scaling operations and working capital.
- Geographic expansion
- Sales and marketing
- Scaling operations
- Working capital
Comparable rounds
How it compares
The closest in time: 1 in Drug Stores & Pharmacies, then Series D rounds in any sector within 6 months:
| Company | Announced | Amount | Post-money | Led by |
|---|---|---|---|---|
| Fuze Health Drug Stores & Pharmacies | 3 Dec 2020 | $250M | $1.00B | SoftBank Vision Fund |
| Dairy Products - Farms & Stores | 16 Jan 2020 | $225M | not disclosed | Qatar Investment Authority |
| Insurance - Agents, Carriers & Brokers | 30 Jan 2020 | $100M | not disclosed | KKR |
| Data Solutions | 13 Jan 2020 | $60M | not disclosed | Georgian |
| Real Estate Investment | 8 Jan 2020 | $50M | not disclosed | SVB Capital |
| Tech Companies | 29 Jan 2020 | $50M | not disclosed | Eminence Capital, LP |
| Tech Companies | 8 Jan 2020 | $42M | not disclosed | Venrock and Highland Capital Partners |
| Medical Supply Manufacturers | 14 Jan 2020 | $13M | not disclosed | Consensus Business Group and Accelmed |
Sources
Where this comes from
Reported by 4 sources.
Questions
Frequently asked
How much did Alto Pharmacy raise in its Series D round?
Alto Pharmacy raised $250M in its Series D round, announced in Jan 2020.
Who led Alto Pharmacy's Series D round?
SoftBank Vision Fund led it, with Greenoaks, Jackson Square Ventures, Olive Tree Capital and Zola Global.
What was Alto Pharmacy's valuation at the Series D round?
$700M post-money ($450M pre-money).
Did Alto Pharmacy raise again after this round?
Yes: a Series E round in Jan 2022 of $200M at $1.70B post-money.